(Date:11/26/2009)...ars, the number of Americans living with diabetes ...n 2009 to 44.1 million in 2034. Over the same peri...g from $113 billion to $336 billion, even with no ... based at the University of Chicago report in the ...of those with diabetes covered by Medicare will ri...
(Date:11/26/2009)...big or too heavy can lead to strains or worse , ...ere may be nothing wrong with stuffing your turkey...e same thing with your suitcase as you pack for ho...ated in 2008 in U.S. hospital emergency rooms, doc...s for luggage-related injuries, such as muscle str...
(Date:11/26/2009)... No more letters from the North Pole, Textsa... messages from Santa , No...perational efficiencies at the North Pole Santa Cl...dren all over the globe informed of his Christmas ...uo;s research department have identified a large a...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a lead...a, today announced the expansion of its services t...t, Dr. Doug Macmillan. , ...is pleased to announce that Dr. Doug Macmillan, an...ed an additional advanced training seminar. RTDen...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free na...az and Yasmin birth control pills who have suffere..., Stroke, Heart Attack or other related cardiac is...all toll free at 1-800-856-6405 or go to the firm&...ill out an online case evaluation form. , ...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3...arch 5 Relax The Back corporation,sold a record n...ficials,have announced 16 franchised locations wer...ives note that 2008 is shaping up to deliver simil...company,s long-term goal is to operate 300 to 320 ...
...arch 5 Parker Waichman Alonso LLP,announces that ...h,Nephrogenic Systemic Fibrosis (NSF) after receiv...ast dye manufactured by General Electric,Company, ...tients with pre-existing kidney disease who have b...
... Family Members Confront Lazard Execs, Protest,Out...RK, March 5 Workers, family members of,elderly re...ealthcare,members confronted private equity owner ...country., Atria -- the third-largest assisted liv...
...lif., March 5 Hundreds of,patients who rely on Co...Mission campus for medical services will be forced... The hospital will shut down the Pediatric and Ob...nt care operations,last year., The Huntington Par...
...enter of ability to control impulsive responses, s...Day News) -- Teens at risk of developing a substan...ctivation, a U.S. study concludes. , The research...en increased risk for a substance abuse disorder a...
...ation modifications to the structure of chromatin...l is a key player in embryonic development and ca...lar Biology Laboratory [EMBL] in Heidelberg now ga...at estrogen causes rapid epigenetic changes in bre...
Other Medicine News:Health News:Relax The Back Announces Record Growth in 2007; Executives Bullish on Specialty Retailer's Prospects for 2008 2Health News:Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan 2Health News:Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan 3Health News:New! Pull Back the Corporate Curtain at www.LazardUnveiled.org 2Health News:Community & Mission Hospital of Huntington Park Shutting Down Mission Campus, Terminating Workers 2Health News:Deficit in Brain Function Puts Teens at Risk of Drug Abuse 2Health News:New revelations in epigenetic control shed light on breast cancer 2(Date:11/25/2009)...AGO and STAFA, Switzerland, Nov. 25 /PRNewswire/ -...cturer of innovative hearing solutions, presented ...Conference, focusing on the special needs of the o...eading experts in aging and audiology from around ...eryday with older people with hearing loss for an ...
(Date:11/25/2009)...RDOVA,Calif.,Nov.25/PRNewswire/--AMPACFineChemical...Nasdaq: APFC )announcedtodaythatitreceivedtheEnvir...nnualStatewideEnvironmentalSummit,sponsoredbytheCa...),theIndustrialEnvironmentalAssociation(IEA)andthe...Diego.Thisisthemostprestigiousawardavailablefromal...
(Date:11/25/2009)... CITY, Calif., Nov. 25 A...ompany manufacturing point-of-care blood analysis ...rman and chief executive officer, will present at ...ce on Wednesday, December 2, 2009 at 2:00 p.m. ET....e Hotel in New York City. ,, About Abaxis ,...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Thomson Reuters Invites You to the First Latin American Forum Covering the Pharmaceutical Industry 54437 1Thomson Reuters Invites You to the First Latin American Forum Covering the Pharmaceutical Industry 54437 2Perrigo Company Announces Quarterly Dividend 54432 1International robotic surgery forum launches in Chicago 54428 1International robotic surgery forum launches in Chicago 54428 2...Threshold,Pharmaceuticals, Inc. (Nasdaq: THLD ), ...of glufosfamide plus gemcitabine were presented at...ing in Barcelona, Spain. In the Phase 2 clinical ...ine for the treatment of advanced pancreatic cance...I: 31-67%) and 32% (95% CI: 16 - 49%),respectively...
...hase 1a SAD Clinical Study -, BRISBANE, Calif., S...d that the company has begun dosing the first,pati...D) clinical trial,evaluating ITMN-191 (also called...-191 is a hepatitis C virus (HCV) protease inhibit...che. InterMune also reported additional,informatio...
Other Medicine Technology:Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 2Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 4InterMune Announces Start of Phase 1b Trial of ITMN-191 2InterMune Announces Start of Phase 1b Trial of ITMN-191 3InterMune Announces Start of Phase 1b Trial of ITMN-191 4... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: